Radiologists and scientists who have training in PET scans and other imaging technologies study how best to use PET scans to predict and diagnose a wide range of diseases and conditions. In 2012, Mayo Clinic received approval from the Food and Drug Administration to produce and administer Choline C-11 injection, which is an imaging agent used during PET scanning to help detect sites of recurrent prostate cancer. Mayo Clinic is the first institution in North America approved to produce Choline C-11.


See a list of publications about PET scans by Mayo authors on PubMed, a service of the National Library of Medicine.